[go: up one dir, main page]

BR9603270A - Forma cristalina biodisponível de cefuroxima axetila - Google Patents

Forma cristalina biodisponível de cefuroxima axetila

Info

Publication number
BR9603270A
BR9603270A BR9603270A BR9603270A BR9603270A BR 9603270 A BR9603270 A BR 9603270A BR 9603270 A BR9603270 A BR 9603270A BR 9603270 A BR9603270 A BR 9603270A BR 9603270 A BR9603270 A BR 9603270A
Authority
BR
Brazil
Prior art keywords
axetilla
cefuroxime
crystalline form
bioavailable
bioavailable crystalline
Prior art date
Application number
BR9603270A
Other languages
English (en)
Inventor
Leonardo Marsili
Angelo Catteneo
Mario Leone
Maurizio Zenoni
Original Assignee
Acs Dobfar Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acs Dobfar Spa filed Critical Acs Dobfar Spa
Publication of BR9603270A publication Critical patent/BR9603270A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BR9603270A 1995-08-03 1996-08-02 Forma cristalina biodisponível de cefuroxima axetila BR9603270A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001716A IT1277426B1 (it) 1995-08-03 1995-08-03 Forma cristallina biodisponibile del cefuroxima axetil

Publications (1)

Publication Number Publication Date
BR9603270A true BR9603270A (pt) 1998-04-28

Family

ID=11372130

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9603270A BR9603270A (pt) 1995-08-03 1996-08-02 Forma cristalina biodisponível de cefuroxima axetila

Country Status (24)

Country Link
US (1) US5677443A (pt)
EP (1) EP0757991B1 (pt)
JP (1) JPH09104685A (pt)
KR (1) KR970010776A (pt)
CN (1) CN1055693C (pt)
AR (1) AR003973A1 (pt)
AT (1) ATE195126T1 (pt)
BR (1) BR9603270A (pt)
CA (1) CA2179359A1 (pt)
DE (1) DE69609576T2 (pt)
DK (1) DK0757991T3 (pt)
ES (1) ES2150052T3 (pt)
FI (1) FI962937A7 (pt)
GR (1) GR3034663T3 (pt)
IL (1) IL118822A (pt)
IT (1) IT1277426B1 (pt)
MX (1) MX9603110A (pt)
PT (1) PT757991E (pt)
RU (1) RU2155767C2 (pt)
SI (1) SI0757991T1 (pt)
TR (1) TR199600691A2 (pt)
TW (1) TW413635B (pt)
UA (1) UA46727C2 (pt)
ZA (1) ZA965234B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725382B1 (fr) * 1994-10-05 1997-01-03 Commissariat Energie Atomique Polyazacycloalcanes, complexes tri-, tetra- ou pentaazamacrocycliques, procede de fabrication de ces polyazacycloalcanes substitues ou non et greffes sur un support et utilisations des polyazacycloalcanes
NZ299077A (en) * 1996-07-26 1998-06-26 Apotex Inc Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf
KR100401284B1 (ko) * 1997-06-03 2004-01-31 주식회사유한양행 1-브로모에틸 아세테이트의 제조방법
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (pt) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
ES2171056T3 (es) * 1998-02-20 2002-08-16 Fako Ilaclari A S Procedimiento para la fabricacion de cefuroxima axetil cristalina soluble.
US6384213B1 (en) 1998-10-23 2002-05-07 Ranbaxy Laboratories Limited Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
IN190849B (pt) * 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
ES2201932B2 (es) * 2001-11-23 2005-03-16 Glaxo Group Limited Composicion farmaceutica.
CN1909889B (zh) * 2004-01-09 2010-06-02 韩美药品株式会社 头孢呋辛酯颗粒及其制备方法
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
WO2007063552A1 (en) * 2005-12-02 2007-06-07 Lupin Limited Stable taste masked formulations of cephalosporins
DE102006019619A1 (de) * 2006-04-25 2007-10-31 Grünenthal GmbH Kristalline Modifikation von Cefuroximaxetil
CN102417451B (zh) * 2011-12-20 2013-12-04 浙江国邦药业有限公司 一种合成（r，s）1-溴代乙基乙酸酯的制备方法
WO2014040239A1 (zh) * 2012-09-12 2014-03-20 海南卫康制药(潜山)有限公司 头孢呋辛钠晶型化合物及其组合物粉针
CN106554361B (zh) * 2016-09-30 2018-10-09 华北制药河北华民药业有限责任公司 一种头孢呋辛酯口服制剂的制备方法
CN115594583A (zh) * 2022-10-13 2023-01-13 浙江东盈药业有限公司（Cn） 一种1-溴乙基乙酸酯的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil

Also Published As

Publication number Publication date
TR199600691A3 (tr) 1998-03-21
ES2150052T3 (es) 2000-11-16
EP0757991B1 (en) 2000-08-02
FI962937L (fi) 1997-02-04
CA2179359A1 (en) 1997-02-04
AU6083396A (en) 1997-02-06
IL118822A (en) 1999-11-30
IT1277426B1 (it) 1997-11-10
AR003973A1 (es) 1998-09-30
US5677443A (en) 1997-10-14
PT757991E (pt) 2000-11-30
ATE195126T1 (de) 2000-08-15
DK0757991T3 (da) 2000-09-04
DE69609576T2 (de) 2001-01-04
EP0757991A1 (en) 1997-02-12
IL118822A0 (en) 1996-10-31
JPH09104685A (ja) 1997-04-22
ZA965234B (en) 1997-03-06
KR970010776A (ko) 1997-03-27
FI962937A7 (fi) 1997-02-04
ITMI951716A1 (it) 1997-02-03
TW413635B (en) 2000-12-01
TR199600691A2 (xx) 1998-03-21
ITMI951716A0 (it) 1995-08-03
DE69609576D1 (de) 2000-09-07
CN1055693C (zh) 2000-08-23
RU2155767C2 (ru) 2000-09-10
AU700214B2 (en) 1998-12-24
GR3034663T3 (en) 2001-01-31
UA46727C2 (uk) 2002-06-17
SI0757991T1 (en) 2000-12-31
MX9603110A (es) 1997-06-28
CN1147516A (zh) 1997-04-16
FI962937A0 (fi) 1996-07-23

Similar Documents

Publication Publication Date Title
BR9603270A (pt) Forma cristalina biodisponível de cefuroxima axetila
BR9711151A (pt) Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida
LT97149A (lt) 2-metil-tieno-benzodiazepino peroralinė vaisto forma
DE69602086D1 (de) Festes waschmittelstück
FI963761A7 (fi) Kefalosporiinin synteesi
DE69634581D1 (de) Antibakterielle Cephalosporine
BR9611062A (pt) Antibioticos de cefalosporina
MA23970A1 (fr) Derives de cephalosporine
FI973500A0 (fi) 3-pyrrolidylideeni-2-oni-kefalosporiinien johdannaiset
PL337612A1 (en) Crystalline form of roxyfiban
BR9610201A (pt) Forma cristalina alternativa de tazofelona
AU700214C (en) Bioavailable crystalline form of cefuroxime axetil
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
BR9603734A (pt) Derivados de cefalosporina
HRP930890B1 (en) The production of crystalline l-sorbose
FI955924A0 (fi) Rengoering av skivvaermevaexlare med effektultraljud
FI952808A0 (fi) Rensapparat foer invaendig rengoering av luftkanaler med rektangulaert tvaersmitt
FIU950441U0 (fi) Glasfoeremaol med bihang av metalltraod
FI930524A0 (fi) Foerfarande foer accelerering av en kompostors funktion
FI933938A0 (fi) Kraftoeverfoeringssystem foer en roterbar kompostor med kontinuerlig funktion
MA23677A1 (fr) Derives de la cephalosporine
IT1275796B1 (it) Gruppo di azionamento di intermittori

Legal Events

Date Code Title Description
FF Decision: intention to grant
HIFF Patent grant cancelled
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
HKEG Application refused (deleted)
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements